Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. These include coronary stents, carotid stents, peripheral stents, bioresorbable or bioabsorbable stents, and renal stents. News included clinical trial data and new technology advances in stents.

Six Months of DAPT Non-Inferior to Twelve in STEMI Patients Receiving Drug-Eluting Stents
News | Antiplatelet and Anticoagulation Therapies | November 06, 2017

November 6, 2017 —  The first trial to evaluate the safety of...

Synergy Stent With Shorter DAPT Superior to Bare-Metal Stent in Elderly Patients
News | Stents Drug Eluting | November 06, 2017

November 6, 2017 — Elderly patients undergoing...

Biotronik Orsiro DES Shows Low Five-Year Event Rates
News | Stents Drug Eluting | November 03, 2017

November 3, 2017 — Biotronik's Orsiro...

Three-Month DAPT Non-Inferior for ACS Patients Treated With Combo Dual Therapy Stent

Image courtesy of OrbusNeich

News | Stents Drug Eluting | November 01, 2017

November 1, 2017 — OrbusNeich reported results from the REDUCE trial in the Late-Breaking Clinical Trial session at...

Double Kissing Crush Two-Stent Technique in Left Main Bifurcation Lesions Demonstrates Lower Target Lesion Failure Rates
News | Stents Bifurcation | November 01, 2017

November 1, 2017 — The double kissing (DK) crush two-stent technique was associated with a lower rate of target...

Thirty-Day ABSORB IV Results Demonstrate Improvements Still Needed in Bioresorbable Stents
News | Stents Bioresorbable | October 31, 2017

October 31, 2017 – Thirty-day results from ABSORB IV, the largest randomized everolimus-eluting...

FDA Investigating Increased Major Adverse Cardiac Event Rates of Absorb Bioresorbable Stent
News | Stents Bioresorbable | October 31, 2017

October 31, 2017 — The U.S. Food and Drug Administration (FDA) issued a warning to healthcare providers that interim...

FDA Approves COBRA REDUCE Trial of 14-Day DAPT With CeloNova Stent
News | Stents | October 27, 2017

October 27, 2017 — CeloNova BioSciences Inc. announced the U.S. Food and Drug Administration (FDA) approved...

News | Stents Drug Eluting | October 25, 2017

October 25, 2017 — Elixir Medical Corp. announced it will unveil a new metallic drug-eluting stent (DES) platform at...

Amaranth Medical to Share Bioresorbable Scaffold Data at TCT
News | Stents Bioresorbable | October 25, 2017

October 25, 2017 — Amaranth Medical will provide an update at the annual Transcatheter Cardiovascular Therapeutics (...

Abbott has pulled the Absorb Bioresorbable scaffold stent off the market.

The biggest cardiac technology story in September was Abbott pulled the Absorb Bioresorbable scaffold stent off the market because poor sales.

Feature | October 02, 2017

October 2, 2017 — Here is the list of the most popular articles and videos on the Diagnostic and Interventional...

Biotronik Studies Demonstrate Efficacy of Minimizing Metal Burden in SFA Therapy
News | Stents Bare Metal | September 22, 2017

September 22, 2017 — Physicians demonstrated that reducing metal burden in...

Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation | September 21, 2017

September 21, 2017 — Cardinal Health and Tryton Medical Inc. announced that the Tryton coronary Side Branch...

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab | September 14, 2017

September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical...

Veniti Announces Boston Scientific Distribution Agreement for Vici Venous Stent
News | Venous Therapies | September 11, 2017

September 11, 2017 — Veniti Inc. announced that Boston Scientific will distribute the Vici Venous Stent under a...

Overlay Init